Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?

Konstantinos Papamichael, Mark T. Osterman, Corey A. Siegel, Gil Y. Melmed, Marla C. Dubinsky, Jean Frederic Colombel, Stephen B. Hanauer, Adam S. Cheifetz

Research output: Contribution to journalLetterpeer-review

17 Scopus citations
Original languageEnglish
Pages (from-to)1201-1202
Number of pages2
Issue number4
StatePublished - Mar 2018

Cite this